Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Accenture
Fish and Richardson
Mallinckrodt
Teva
Fuji
Federal Trade Commission
AstraZeneca
McKinsey
Colorcon

Generated: December 11, 2017

DrugPatentWatch Database Preview

Escitalopram oxalate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for escitalopram oxalate and what is the scope of escitalopram oxalate freedom to operate?

Escitalopram oxalate
is the generic ingredient in two branded drugs marketed by Mylan Pharms Inc, Amneal Pharms, Antrim Pharms Llc, Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Macleods Pharms Ltd, Silarx Pharms Inc, Taro, Forest Labs, Accord Hlthcare, Apotex Inc, Hikma Pharms, Invagen Pharms, Jubilant Generics, Lupin Ltd, Prinston Inc, Sti Pharma Llc, Teva Pharms Usa, Torrent Pharms Ltd, and Zydus Pharms Usa Inc, and is included in twenty-five NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for escitalopram oxalate. Fifty-nine suppliers are listed for this compound. There are six tentative approvals for this compound.

Summary for escitalopram oxalate

Pharmacology for escitalopram oxalate

Tentative approvals for ESCITALOPRAM OXALATE

Applicant Application No. Strength Dosage Form
u► Subscribe5MGTABLET; ORAL
u► Subscribe20MGTABLET; ORAL
u► Subscribe10MGTABLET; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Apotex IncESCITALOPRAM OXALATEescitalopram oxalateTABLET;ORAL078777-003Sep 11, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Lupin LtdESCITALOPRAM OXALATEescitalopram oxalateTABLET;ORAL078169-003Sep 11, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Jubilant GenericsESCITALOPRAM OXALATEescitalopram oxalateTABLET;ORAL202280-001Sep 12, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva Pharms UsaESCITALOPRAM OXALATEescitalopram oxalateTABLET;ORAL076765-002Mar 14, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Amneal PharmsESCITALOPRAM OXALATEescitalopram oxalateTABLET;ORAL205619-003May 17, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma PharmsESCITALOPRAM OXALATEescitalopram oxalateTABLET;ORAL078766-003Sep 11, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncESCITALOPRAM OXALATEescitalopram oxalateCAPSULE;ORAL077660-001Jul 31, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva Pharms UsaESCITALOPRAM OXALATEescitalopram oxalateTABLET;ORAL076765-003Mar 14, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Invagen PharmsESCITALOPRAM OXALATEescitalopram oxalateTABLET;ORAL078604-002Sep 11, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sti Pharma LlcESCITALOPRAM OXALATEescitalopram oxalateTABLET;ORAL077512-003Sep 12, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: escitalopram oxalate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Forest LabsLEXAPROescitalopram oxalateSOLUTION;ORAL021365-001Nov 27, 2002► Subscribe► Subscribe
Forest LabsLEXAPROescitalopram oxalateTABLET;ORAL021323-003Aug 14, 2002► Subscribe► Subscribe
Forest LabsLEXAPROescitalopram oxalateTABLET;ORAL021323-002Aug 14, 2002► Subscribe► Subscribe
Forest LabsLEXAPROescitalopram oxalateTABLET;ORAL021323-001Aug 14, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Boehringer Ingelheim
Healthtrust
QuintilesIMS
Medtronic
US Army
Colorcon
Baxter
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot